Unité de Fabrication des Médicaments S.A (BVMT:UMED)
Tunisia · Delayed Price · Currency is TND 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
BVMT:UMED Income Statement
Financials in millions TND. Fiscal year is January - December.
Millions TND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 141.08 | 148.91 | 147.68 | 136 | 96.36 | 84.5 |
Other Revenue | 0.53 | - | - | - | - | 0.01 |
| 141.61 | 148.91 | 147.68 | 136 | 96.36 | 84.51 | |
Revenue Growth | -7.96% | 0.84% | 8.58% | 41.14% | 14.02% | -7.17% |
Cost of Revenue | 59.14 | 62.47 | 66.87 | 61.72 | 46.8 | 38.22 |
Gross Profit | 82.46 | 86.44 | 80.8 | 74.29 | 49.56 | 46.29 |
Selling, General & Admin | 22.12 | 21.47 | 21.11 | 19.71 | 16.77 | 15.48 |
Other Operating Expenses | 11.49 | 11 | 9.85 | 9.88 | 8.27 | 6.87 |
Operating Expenses | 45.94 | 52.69 | 47.43 | 45.18 | 35.95 | 32.55 |
Operating Income | 36.52 | 33.75 | 33.37 | 29.11 | 13.61 | 13.74 |
Interest Expense | -4.97 | -6.1 | -6.9 | -6.22 | -3.6 | -2.63 |
Interest & Investment Income | 0.53 | 0.85 | 0.32 | 0.09 | 0.19 | 0.28 |
Currency Exchange Gain (Loss) | -0.24 | -0.24 | 0.18 | -0.48 | -0.05 | -0.48 |
Other Non Operating Income (Expenses) | -6.58 | -0.15 | 0.09 | -11.3 | -0.22 | -0.45 |
EBT Excluding Unusual Items | 25.26 | 28.11 | 27.07 | 11.21 | 9.94 | 10.47 |
Gain (Loss) on Sale of Assets | 0.17 | 0.17 | - | 0.08 | 0.09 | 0.04 |
Asset Writedown | -2.29 | -2.29 | -0.1 | -0.3 | -0.2 | -0.08 |
Pretax Income | 23.14 | 25.99 | 26.97 | 10.99 | 9.83 | 10.43 |
Income Tax Expense | 6.12 | 7.39 | 7.6 | 5.45 | 2 | 1.72 |
Earnings From Continuing Operations | 17.01 | 18.6 | 19.37 | 5.55 | 7.83 | 8.7 |
Net Income | 17.01 | 18.6 | 19.37 | 5.55 | 7.83 | 8.7 |
Net Income to Common | 17.01 | 18.6 | 19.37 | 5.55 | 7.83 | 8.7 |
Net Income Growth | -23.41% | -3.98% | 249.30% | -29.17% | -10.03% | 24.69% |
Shares Outstanding (Basic) | - | 32 | 32 | 32 | 32 | 32 |
Shares Outstanding (Diluted) | - | 32 | 32 | 32 | 32 | 32 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | - | 0.58 | 0.61 | 0.17 | 0.24 | 0.27 |
EPS (Diluted) | - | 0.58 | 0.61 | 0.17 | 0.24 | 0.27 |
EPS Growth | - | -3.98% | 249.31% | -29.17% | -10.03% | 24.69% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 26.66 | 15.99 | 10.58 | 18.68 | -12.07 | 15.13 |
Free Cash Flow Per Share | - | 0.50 | 0.33 | 0.58 | -0.38 | 0.47 |
Dividend Per Share | - | - | 0.570 | - | 0.469 | 0.406 |
Dividend Growth | - | - | - | - | 15.52% | - |
Gross Margin | 58.23% | 58.05% | 54.72% | 54.62% | 51.43% | 54.77% |
Operating Margin | 25.79% | 22.66% | 22.60% | 21.40% | 14.12% | 16.26% |
Profit Margin | 12.02% | 12.49% | 13.12% | 4.08% | 8.13% | 10.30% |
Free Cash Flow Margin | 18.83% | 10.74% | 7.16% | 13.73% | -12.52% | 17.90% |
EBITDA | 37.81 | 42.94 | 43.39 | 39.11 | 23.3 | 23.02 |
EBITDA Margin | 26.70% | 28.84% | 29.39% | 28.75% | 24.19% | 27.24% |
D&A For EBITDA | 1.29 | 9.19 | 10.02 | 10 | 9.69 | 9.27 |
EBIT | 36.52 | 33.75 | 33.37 | 29.11 | 13.61 | 13.74 |
EBIT Margin | 25.79% | 22.66% | 22.60% | 21.40% | 14.12% | 16.26% |
Effective Tax Rate | 26.46% | 28.44% | 28.17% | 49.56% | 20.35% | 16.52% |
Revenue as Reported | 141.72 | 149.02 | 147.87 | 136.15 | 96.62 | 84.55 |